• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向有机金属抗血吸虫病候选药物。

Toward organometallic antischistosomal drug candidates.

作者信息

Hess Jeannine, Keiser Jennifer, Gasser Gilles

机构信息

Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.

出版信息

Future Med Chem. 2015;7(6):821-30. doi: 10.4155/fmc.15.22.

DOI:10.4155/fmc.15.22
PMID:25996072
Abstract

In the recent years, there has been a growing interest in the use of novel approaches for the treatment of parasitic diseases such as schistosomiasis. Among the different approaches used, organometallic compounds were found to offer unique opportunities in the design of antiparasitic drug candidates. A ferrocenyl derivative, namely ferroquine, has even entered clinical trials as a novel antimalarial. In this short review, we report on the studies describing the use of organometallic compounds against schistosomiasis.

摘要

近年来,人们对使用新方法治疗血吸虫病等寄生虫病的兴趣日益浓厚。在所使用的不同方法中,发现有机金属化合物在设计抗寄生虫候选药物方面提供了独特的机会。一种二茂铁基衍生物,即二茂铁喹,甚至已作为一种新型抗疟药进入临床试验阶段。在这篇简短的综述中,我们报告了描述使用有机金属化合物治疗血吸虫病的研究。

相似文献

1
Toward organometallic antischistosomal drug candidates.迈向有机金属抗血吸虫病候选药物。
Future Med Chem. 2015;7(6):821-30. doi: 10.4155/fmc.15.22.
2
Schistosomiasis control: praziquantel forever?血吸虫病防治:吡喹酮会一直使用吗?
Mol Biochem Parasitol. 2014 Jun;195(1):23-9. doi: 10.1016/j.molbiopara.2014.06.002. Epub 2014 Jun 21.
3
Natural products with antischistosomal activity.具有抗血吸虫活性的天然产物。
Future Med Chem. 2015;7(6):801-20. doi: 10.4155/fmc.15.23.
4
Drugs for the control of parasitic diseases: current status and development in schistosomiasis.用于控制寄生虫病的药物:血吸虫病的现状与发展
Trends Parasitol. 2003 Nov;19(11):509-15. doi: 10.1016/j.pt.2003.09.005.
5
Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.抗血吸虫病药物及制剂合成的最新进展
Mini Rev Med Chem. 2017;17(5):467-484. doi: 10.2174/1389557513666131119204558.
6
Design, synthesis and biological evaluation of praziquantel and endoperoxide conjugates as antischistosomal agents.吡喹酮与内过氧化物缀合物作为抗血吸虫药物的设计、合成及生物学评价
Future Med Chem. 2015;7(6):713-25. doi: 10.4155/fmc.15.20.
7
Chemotherapy for Fighting Schistosomiasis: Past, Present and Future.化疗治疗血吸虫病:过去、现在和未来。
ChemMedChem. 2018 Nov 20;13(22):2374-2389. doi: 10.1002/cmdc.201800572. Epub 2018 Nov 7.
8
Could we expect new praziquantel derivatives? A meta pharmacometrics/pharmacoinformatics analysis of all antischistosomal praziquantel derivatives found in the literature.我们能否期待新的吡喹酮衍生物?对文献中所有抗血吸虫吡喹酮衍生物的荟萃药物代谢动力学/药物信息学分析。
SAR QSAR Environ Res. 2019 Jun;30(6):383-401. doi: 10.1080/1062936X.2019.1607898.
9
[Advances in research on antischistosomal drugs].抗血吸虫病药物的研究进展
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2011 Jun;23(3):337-9.
10
Praziquantel.吡喹酮
Parasitol Res. 2003 Jun;90 Supp 1:S3-9. doi: 10.1007/s00436-002-0751-z. Epub 2002 Nov 22.

引用本文的文献

1
Praziquantel resistance in schistosomes: a brief report.血吸虫对吡喹酮的耐药性:简要报告。
Front Parasitol. 2024 Oct 2;3:1471451. doi: 10.3389/fpara.2024.1471451. eCollection 2024.
2
Small change, big difference: A promising praziquantel derivative designated P96 with broad-spectrum antischistosomal activity for chemotherapy of schistosomiasis japonica.微小的变化,巨大的差异:一种有前途的吡喹酮衍生物 P96,具有广谱抗血吸虫活性,可用于日本血吸虫病的化疗。
PLoS Negl Trop Dis. 2023 Jul 6;17(7):e0011215. doi: 10.1371/journal.pntd.0011215. eCollection 2023 Jul.
3
Bioorganometallic Compounds as Novel Drug Targets against Schistosomiasis in Sub-Saharan Africa: An alternative to Praziquantel?
生物有机金属化合物作为撒哈拉以南非洲地区抗血吸虫病的新型药物靶点:吡喹酮的替代品?
Adv Pharm Bull. 2022 Mar;12(2):283-297. doi: 10.34172/apb.2022.029. Epub 2021 May 30.
4
Rational approaches towards inorganic and organometallic antibacterials.理性方法对抗无机和有机金属抗菌剂。
Biol Chem. 2021 Jul 13;403(4):363-375. doi: 10.1515/hsz-2021-0253. Print 2022 Mar 28.
5
β-Diketonate versus β-Ketoiminate: The Importance of a Ferrocenyl Moiety in Improving the Anticancer Potency.β-二酮酸酯与β-酮亚胺酸酯:二茂铁基在提高抗癌活性方面的重要性。
Chembiochem. 2020 Jul 16;21(14):1988-1996. doi: 10.1002/cbic.202000028. Epub 2020 Apr 2.
6
The ABL kinase inhibitor imatinib causes phenotypic changes and lethality in adult Schistosoma japonicum.ABL激酶抑制剂伊马替尼可导致日本血吸虫成虫出现表型变化并致死。
Parasitol Res. 2019 Mar;118(3):881-890. doi: 10.1007/s00436-019-06224-x. Epub 2019 Feb 7.
7
Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates.作为新型抗血吸虫病候选药物的抗疟药甲氟喹有机金属衍生物的合成、表征及生物活性
Medchemcomm. 2018 Oct 10;9(11):1905-1909. doi: 10.1039/c8md00396c. eCollection 2018 Nov 1.
8
Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.应用扫描电子显微镜评估体外接触三价铁茂、二价钌茂和苯甲酰氧喹啉衍生物后曼氏血吸虫和埃及血吸虫表皮损伤。
Parasit Vectors. 2018 Nov 6;11(1):580. doi: 10.1186/s13071-018-3132-x.
9
Inhibition of the Ras/Raf interaction and repression of renal cancer xenografts by an enantiomeric iridium(iii) metal-based compound.一种对映体铱(III)金属基化合物对Ras/Raf相互作用的抑制及对肾癌异种移植瘤的抑制作用
Chem Sci. 2017 Jul 1;8(7):4756-4763. doi: 10.1039/c7sc00311k. Epub 2017 May 16.
10
Characterization of the Activities of Dinuclear Thiolato-Bridged Arene Ruthenium Complexes against Toxoplasma gondii.二硫醇桥联芳基金属钌配合物抗弓形虫活性的表征。
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.01031-17. Print 2017 Sep.